AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 20305865 — intervention group
Group type: COMPARATOR
Intervention: Scaling and root planing (SRP)
Number of subjects: 97
Study 20305865 — intervention group
Group type: COMPARATOR
Intervention: Scaling and root planing with placebo tablets (CP)
Number of subjects: 97
Study 18534556 — intervention group
Group type: EXPERIMENTAL
Intervention: N-acetyl cysteine (NAC) 1 g twice daily adjunctive to usual medication
Number of subjects: 75
Study 15915863 — intervention group
Group type: EXPERIMENTAL
Intervention: HPL method of instruction
Number of subjects: 2
Study 15915863 — intervention group
Group type: COMPARATOR
Intervention: Standard lecture sequence
Number of subjects: 2
Study 12074271 — intervention group
Group type: EXPERIMENTAL
Intervention: Aprindine (40 mg/day)
Number of subjects: 141
Study 12074271 — intervention group
Group type: EXPERIMENTAL
Intervention: Digoxin (0.25 mg/day)
Number of subjects: 141
Study 12074271 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 141
Study 12074271 — intervention group
Group type: EXPERIMENTAL
Intervention: Aprindine vs Placebo
Number of subjects: 141
Study 12074271 — intervention group
Group type: EXPERIMENTAL
Intervention: Digoxin vs Placebo
Number of subjects: 141
Study 9951791 — intervention group
Group type: EXPERIMENTAL
Intervention: Isometric and isotonic exercise until exhaustion
Number of subjects: 110
Study 7776678 — intervention group
Group type: EXPERIMENTAL
Intervention: Leukocyte filter
Number of subjects: 32
Study 7776678 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 32
Study 2334012 — intervention group
Group type: EXPERIMENTAL
Intervention: Chlorhexidine surgical scrub left on hands
Number of subjects: 50
Study 2334012 — intervention group
Group type: COMPARATOR
Intervention: Standard rinse of one hand
Number of subjects: 50
Study 323659 — intervention group
Group type: EXPERIMENTAL
Intervention: Dalkon Shield
Number of subjects: 0
Study 323659 — intervention group
Group type: COMPARATOR
Intervention: Lippes Loop
Number of subjects: 0
Study 323659 — intervention group
Group type: COMPARATOR
Intervention: Inhiband
Number of subjects: 0
Study 30898608 — intervention group
Group type: EXPERIMENTAL
Intervention: Ticagrelor (180-mg loading dose, 90 mg twice daily thereafter)
Number of subjects: 3799
Study 30898608 — intervention group
Group type: COMPARATOR
Intervention: Clopidogrel (300- to 600-mg loading dose, 75 mg daily thereafter)
Number of subjects: 3799
Study 28551840 — intervention group
Group type: EXPERIMENTAL
Intervention: Endometrial scratching
Number of subjects: 144
Study 28551840 — intervention group
Group type: COMPARATOR
Intervention: Control (no endometrial scratching)
Number of subjects: 144
Study 25556301 — intervention group
Group type: EXPERIMENTAL
Intervention: Partial-body cryotherapy (PBC) at -110 °C for 3 minutes
Number of subjects: 26
Study 25556301 — intervention group
Group type: COMPARATOR
Intervention: Control group exposed to 21 °C for 3 minutes
Number of subjects: 26
Study 23092143 — intervention group
Group type: EXPERIMENTAL
Intervention: EB (Adper Easy Bond application)
Number of subjects: 32
Study 23092143 — intervention group
Group type: EXPERIMENTAL
Intervention: EB+B (Adper Easy Bond followed by hydrophobic resin coat)
Number of subjects: 32
Study 23092143 — intervention group
Group type: COMPARATOR
Intervention: Comparison between EB and EB+B
Number of subjects: 32
Study 21613575 — intervention group
Group type: COMPARATOR
Intervention: Quercetin (2,000 mg/day)
Number of subjects: 8
Study 21613575 — intervention group
Group type: EXPERIMENTAL
Intervention: Placebo
Number of subjects: 8
Study 20128316 — intervention group
Group type: EXPERIMENTAL
Intervention: Enamel Care dentifrice
Number of subjects: 208
Study 20128316 — intervention group
Group type: COMPARATOR
Intervention: Control dentifrice
Number of subjects: 208
Study 17102716 — intervention group
Group type: EXPERIMENTAL
Intervention: Humorous movies
Number of subjects: 29
Study 17102716 — intervention group
Group type: COMPARATOR
Intervention: Neutral movies
Number of subjects: 29
Study 15607664 — intervention group
Group type: EXPERIMENTAL
Intervention: Left Ventricular Assist Devices (LVADs)
Number of subjects: 129
Study 15607664 — intervention group
Group type: COMPARATOR
Intervention: Optimal Medical Management (OMM)
Number of subjects: 129
Study 11300445 — intervention group
Group type: EXPERIMENTAL
Intervention: Metformin 500 mg twice daily
Number of subjects: 44
Study 11300445 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 44
Study 9420539 — intervention group
Group type: EXPERIMENTAL
Intervention: Wax-carbon-laser treatment
Number of subjects: 12
Study 9420539 — intervention group
Group type: EXPERIMENTAL
Intervention: Wax-laser treatment
Number of subjects: 12
Study 9420539 — intervention group
Group type: EXPERIMENTAL
Intervention: Laser alone
Number of subjects: 12
Study 9420539 — intervention group
Group type: COMPARATOR
Intervention: Wax control
Number of subjects: 12
Study 7905033 — intervention group
Group type: EXPERIMENTAL
Intervention: 16-item Negative Symptom Assessment (NSA-16)
Number of subjects: 499
Study 7905033 — intervention group
Group type: EXPERIMENTAL
Intervention: NSA-16
Number of subjects: 499
Study 3318724 — intervention group
Group type: EXPERIMENTAL
Intervention: 12.5 micrograms ethinyloestradiol
Number of subjects: 10
Study 30144985 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-level laser therapy (LLLT)
Number of subjects: 42
Study 30144985 — intervention group
Group type: COMPARATOR
Intervention: Placebo (mock laser therapy)
Number of subjects: 42
Study 30144985 — intervention group
Group type: COMPARATOR
Intervention: Control (no laser applied)
Number of subjects: 42
Study 27716336 — intervention group
Group type: EXPERIMENTAL
Intervention: Adaptive cognitive training (ADAPT-gr) using COGNI-TRAcK with automatic adjustment of task difficulty.
Number of subjects: 28
Study 27716336 — intervention group
Group type: COMPARATOR
Intervention: Non-adaptive cognitive training (CONST-gr) using COGNI-TRAcK at constant difficulty levels.
Number of subjects: 28
Study 24594059 — intervention group
Group type: EXPERIMENTAL
Intervention: Food intake (postprandial conditions)
Number of subjects: 16
Study 22402954 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin C (2 g)
Number of subjects: 80
Study 22402954 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 80
Study 20696564 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasound guidance for epidural placement
Number of subjects: 370
Study 20696564 — intervention group
Group type: COMPARATOR
Intervention: Control group (no ultrasound guidance)
Number of subjects: 370
Study 18487005 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard CPR plus active impedance threshold device (ITD)
Number of subjects: 14742
Study 18487005 — intervention group
Group type: COMPARATOR
Intervention: Standard CPR plus sham ITD
Number of subjects: 14742
Study 18487005 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard CPR plus active ITD
Number of subjects: 14742
Study 15969867 — intervention group
Group type: EXPERIMENTAL
Intervention: Olopatadine 0.2%
Number of subjects: 500
Study 15969867 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 500
Study 12795770 — intervention group
Group type: EXPERIMENTAL
Intervention: Alefacept 15 mg IM
Number of subjects: 507
Study 12795770 — intervention group
Group type: EXPERIMENTAL
Intervention: Alefacept 10 mg IM
Number of subjects: 507
Study 12795770 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 507
Study 10569747 — intervention group
Group type: EXPERIMENTAL
Intervention: CVD 103-HgR (2 x 10(8) to 8 x 10(8) CFU)
Number of subjects: 85
Study 10569747 — intervention group
Group type: COMPARATOR
Intervention: Placebo (killed E. coli K-12)
Number of subjects: 85
Study 8644628 — intervention group
Group type: EXPERIMENTAL
Intervention: Enalapril
Number of subjects: 0
Study 1871078 — intervention group
Group type: EXPERIMENTAL
Intervention: Nurse-assisted self-quit training
Number of subjects: 3161
Study 1871078 — intervention group
Group type: EXPERIMENTAL
Intervention: Nurse-assisted recruitment to a group program
Number of subjects: 3161
Study 1871078 — intervention group
Group type: EXPERIMENTAL
Intervention: Nurse-assisted combination intervention
Number of subjects: 3161
Study 1871078 — intervention group
Group type: COMPARATOR
Intervention: Brief physician advice only
Number of subjects: 3161
Study 1871078 — intervention group
Group type: EXPERIMENTAL
Intervention: Nurse-assisted interventions (all types)
Number of subjects: 3161
Study 6861861 — intervention group
Group type: EXPERIMENTAL
Intervention: Zopiclone 5 mg
Number of subjects: 0
Study 6861861 — intervention group
Group type: EXPERIMENTAL
Intervention: Zopiclone 10 mg
Number of subjects: 0
Study 6861861 — intervention group
Group type: EXPERIMENTAL
Intervention: Nitrazepam 5 mg
Number of subjects: 0
Study 6861861 — intervention group
Group type: EXPERIMENTAL
Intervention: Nitrazepam 10 mg
Number of subjects: 0
Study 6861861 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 30957654 — intervention group
Group type: EXPERIMENTAL
Intervention: Labeling condition (e.g., 'sex offenders', 'murderers')
Number of subjects: 310
Study 30957654 — intervention group
Group type: COMPARATOR
Intervention: Neutral condition (e.g., 'people who have committed crimes of a sexual nature')
Number of subjects: 310
Study 30452511 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical tazarotene gel, 0.1%, applied once every night for 3 months.
Number of subjects: 36
Study 30452511 — intervention group
Group type: COMPARATOR
Intervention: Microneedling therapy with a dermaroller (1.5 mm needle length) for a total of 4 sessions over 3 months.
Number of subjects: 36
Study 30452511 — intervention group
Group type: EXPERIMENTAL
Intervention: Patient global assessment score (0-10 scale) for satisfaction at follow-up visits.
Number of subjects: 36
Study 30452511 — intervention group
Group type: EXPERIMENTAL
Intervention: Goodman and Baron quantitative and qualitative scores for acne scar severity.
Number of subjects: 36
Study 28756871 — intervention group
Group type: COMPARATOR
Intervention: Paclitaxel (80mg/m2 intravenously days 1, 8, and 15 every 4 weeks)
Number of subjects: 108
Study 28756871 — intervention group
Group type: EXPERIMENTAL
Intervention: Paclitaxel (80mg/m2 intravenously days 1, 8, and 15) plus reovirus (3×10^10 TCID50/day intravenously on days 1-5)
Number of subjects: 108
Study 24848975 — intervention group
Group type: EXPERIMENTAL
Intervention: PRGF (one dose)
Number of subjects: 100
Study 24848975 — intervention group
Group type: EXPERIMENTAL
Intervention: PRGF (two doses)
Number of subjects: 100
Study 24848975 — intervention group
Group type: EXPERIMENTAL
Intervention: PRGF plus HA (two doses)
Number of subjects: 100
Study 24848975 — intervention group
Group type: COMPARATOR
Intervention: Standard care (control group)
Number of subjects: 100
Study 23592741 — intervention group
Group type: COMPARATOR
Intervention: Healthy Eating diet
Number of subjects: 120
Study 23592741 — intervention group
Group type: EXPERIMENTAL
Intervention: Mediterranean diet
Number of subjects: 120
Study 21734512 — intervention group
Group type: EXPERIMENTAL
Intervention: 20-hour manualized group cognitive behavior therapy program
Number of subjects: 17
Study 21734512 — intervention group
Group type: COMPARATOR
Intervention: Wait-list control group
Number of subjects: 17
Study 19521894 — intervention group
Group type: EXPERIMENTAL
Intervention: Nicotinic acid 16.7 mg
Number of subjects: 72
Study 19521894 — intervention group
Group type: EXPERIMENTAL
Intervention: Nicotinic acid up to 50.1 mg
Number of subjects: 72
Study 19521894 — intervention group
Group type: EXPERIMENTAL
Intervention: Nicotinic acid (all doses)
Number of subjects: 72
Study 16720057 — intervention group
Group type: EXPERIMENTAL
Intervention: candesartan
Number of subjects: 40
Study 16720057 — intervention group
Group type: COMPARATOR
Intervention: amlodipine
Number of subjects: 40
Study 15084937 — intervention group
Group type: EXPERIMENTAL
Intervention: Mycophenolate mofetil (MMF) and sirolimus (Sir)
Number of subjects: 31
Study 12201348 — intervention group
Group type: EXPERIMENTAL
Intervention: Acetazolamide
Number of subjects: 12
Study 9150621 — intervention group
Group type: EXPERIMENTAL
Intervention: BMS 180048 150 mg
Number of subjects: 216
Study 9150621 — intervention group
Group type: EXPERIMENTAL
Intervention: BMS 180048 200 mg
Number of subjects: 216
Study 9150621 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 216
Study 8122735 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined epidural and general anaesthesia and postoperative epidural analgesia (CEGA)
Number of subjects: 50
Study 8122735 — intervention group
Group type: COMPARATOR
Intervention: General anaesthesia and postoperative intravenous morphine infusion (GA)
Number of subjects: 50
Study 8122735 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined epidural and general anaesthesia (CEGA)
Number of subjects: 50
Study 8122735 — intervention group
Group type: COMPARATOR
Intervention: General anaesthesia (GA)
Number of subjects: 50
Study 2442559 — intervention group
Group type: EXPERIMENTAL
Intervention: lisinopril 5 mg/day
Number of subjects: 129
Study 2442559 — intervention group
Group type: COMPARATOR
Intervention: captopril 37.5 mg/day
Number of subjects: 129
Study 29099420 — intervention group
Group type: COMPARATOR
Intervention: Standard oxygen
Number of subjects: 0
Study 29099420 — intervention group
Group type: COMPARATOR
Intervention: High-flow nasal cannula oxygen
Number of subjects: 0
Study 29099420 — intervention group
Group type: COMPARATOR
Intervention: Noninvasive ventilation
Number of subjects: 0
Study 29410934 — intervention group
Group type: EXPERIMENTAL
Intervention: Lurasidone 80mg
Number of subjects: 488
Study 29410934 — intervention group
Group type: EXPERIMENTAL
Intervention: Lurasidone 160mg
Number of subjects: 488
Study 29410934 — intervention group
Group type: EXPERIMENTAL
Intervention: Quetiapine XR 600mg
Number of subjects: 488
Study 29410934 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 488
Study 29410934 — intervention group
Group type: EXPERIMENTAL
Intervention: Flexible-dose lurasidone (40 to 160mg/d)
Number of subjects: 488
Study 29410934 — intervention group
Group type: EXPERIMENTAL
Intervention: Flexible-dose quetiapine XR (200 to 800mg/d)
Number of subjects: 488
Study 29410934 — intervention group
Group type: EXPERIMENTAL
Intervention: All treatment groups
Number of subjects: 488
Study 26268736 — intervention group
Group type: EXPERIMENTAL
Intervention: RAMP-DM intervention
Number of subjects: 18188
Study 26268736 — intervention group
Group type: COMPARATOR
Intervention: Control group (usual primary care)
Number of subjects: 18188
Study 24093858 — intervention group
Group type: EXPERIMENTAL
Intervention: Functional electrical stimulation (FES)
Number of subjects: 30
Study 24093858 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study 21346065 — intervention group
Group type: EXPERIMENTAL
Intervention: Hesperidin (500 mg once daily for 3 weeks)
Number of subjects: 24
Study 21346065 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study 18564150 — intervention group
Group type: EXPERIMENTAL
Intervention: Sildenafil citrate (50 or 100 mg, as needed)
Number of subjects: 209
Study 18564150 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 209
Study 17263129 — intervention group
Group type: EXPERIMENTAL
Intervention: Deferasirox
Number of subjects: 586
Study 17263129 — intervention group
Group type: COMPARATOR
Intervention: Deferoxamine
Number of subjects: 586
Study 14703887 — intervention group
Group type: EXPERIMENTAL
Intervention: Endoscopic haemoclip
Number of subjects: 93
Study 14703887 — intervention group
Group type: COMPARATOR
Intervention: Heater probe thermocoagulation plus hypertonic saline‐epinephrine injection
Number of subjects: 93
Study 10917577 — intervention group
Group type: EXPERIMENTAL
Intervention: Endovascular sclerotherapy (ES)
Number of subjects: 121
Study 10917577 — intervention group
Group type: COMPARATOR
Intervention: Surgery + sclerotherapy
Number of subjects: 121
Study 10917577 — intervention group
Group type: COMPARATOR
Intervention: Surgery only
Number of subjects: 121
Study 9010710 — intervention group
Group type: EXPERIMENTAL
Intervention: Moexipril alone
Number of subjects: 12
Study 9010710 — intervention group
Group type: EXPERIMENTAL
Intervention: Moexipril with hydrochlorothiazide
Number of subjects: 12
Study 9010710 — intervention group
Group type: COMPARATOR
Intervention: Hydrochlorothiazide alone
Number of subjects: 12
Study 9010710 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydrochlorothiazide with moexipril
Number of subjects: 12
Study 1313682 — intervention group
Group type: EXPERIMENTAL
Intervention: Itraconazole (200 mg twice daily)
Number of subjects: 28
Study 1313682 — intervention group
Group type: COMPARATOR
Intervention: Amphotericin B (0.3 mg/kg daily) plus flucytosine (150 mg/kg daily)
Number of subjects: 28
Study 1313682 — intervention group
Group type: EXPERIMENTAL
Intervention: Itraconazole
Number of subjects: 28
Study 1313682 — intervention group
Group type: COMPARATOR
Intervention: Amphotericin B plus flucytosine
Number of subjects: 28
Study 1313682 — intervention group
Group type: EXPERIMENTAL
Intervention: Cerebrospinal fluid culture positive at 6 weeks
Number of subjects: 28
Study 4048901 — intervention group
Group type: EXPERIMENTAL
Intervention: TDB (De‐Nol)
Number of subjects: 40
Study 4048901 — intervention group
Group type: COMPARATOR
Intervention: Cimetidine
Number of subjects: 40
Study 31204320 — intervention group
Group type: EXPERIMENTAL
Intervention: RECIPROC system
Number of subjects: 75
Study 31204320 — intervention group
Group type: EXPERIMENTAL
Intervention: ProTaper NEXT system
Number of subjects: 75
Study 31204320 — intervention group
Group type: EXPERIMENTAL
Intervention: ProTaper GOLD system
Number of subjects: 75
Study 31204320 — intervention group
Group type: EXPERIMENTAL
Intervention: RECIPROC blue system
Number of subjects: 75
Study 31204320 — intervention group
Group type: COMPARATOR
Intervention: Control group (No preparation)
Number of subjects: 75
Study 30602637 — intervention group
Group type: EXPERIMENTAL
Intervention: Celecoxib
Number of subjects: 135
Study 30602637 — intervention group
Group type: EXPERIMENTAL
Intervention: Ibuprofen
Number of subjects: 135
Study 30602637 — intervention group
Group type: EXPERIMENTAL
Intervention: Tramadol
Number of subjects: 135
Study 26967937 — intervention group
Group type: EXPERIMENTAL
Intervention: Subthalamic nucleus deep brain stimulation (STN‐DBS) + optimal drug therapy (ODT)
Number of subjects: 0
Study 26967937 — intervention group
Group type: COMPARATOR
Intervention: Optimal drug therapy (ODT)
Number of subjects: 0
Study 25267694 — intervention group
Group type: EXPERIMENTAL
Intervention: Heart rate at 80 bpm and tidal volume at 6 mL/kg
Number of subjects: 18
Study 25267694 — intervention group
Group type: EXPERIMENTAL
Intervention: Heart rate at 110 bpm and tidal volume at 6 mL/kg
Number of subjects: 18
Study 25267694 — intervention group
Group type: EXPERIMENTAL
Intervention: Heart rate at 80 bpm and tidal volume at 10 mL/kg
Number of subjects: 18
Study 25267694 — intervention group
Group type: EXPERIMENTAL
Intervention: Heart rate at 110 bpm and tidal volume at 10 mL/kg
Number of subjects: 18
Study 25267694 — intervention group
Group type: COMPARATOR
Intervention: Increasing tidal volume from 6 mL/kg to 10 mL/kg
Number of subjects: 18
Study 22932705 — intervention group
Group type: EXPERIMENTAL
Intervention: Levosimendan (LEVO)
Number of subjects: 33
Study 22932705 — intervention group
Group type: COMPARATOR
Intervention: Furosemide (Controls)
Number of subjects: 33
Study 20209259 — intervention group
Group type: EXPERIMENTAL
Intervention: Vaginoscopy with physiological saline (0.9% NaCl)
Number of subjects: 117
Study 20209259 — intervention group
Group type: COMPARATOR
Intervention: Standard technique with carbon dioxide (CO2)
Number of subjects: 117
Study 17245607 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral Appliance (OA) therapy
Number of subjects: 20
Study 17245607 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous Positive Airway Pressure (CPAP) therapy
Number of subjects: 20
Study 17245607 — intervention group
Group type: COMPARATOR
Intervention: Control group (no treatment)
Number of subjects: 20
Study 15754377 — intervention group
Group type: EXPERIMENTAL
Intervention: Budesonide 6 mg/d and UDCA 15 mg/kg/d
Number of subjects: 77
Study 15754377 — intervention group
Group type: COMPARATOR
Intervention: UDCA 15 mg/kg/d
Number of subjects: 77
Study 12296610 — intervention group
Group type: EXPERIMENTAL
Intervention: Orlistat
Number of subjects: 531
Study 10549401 — intervention group
Group type: EXPERIMENTAL
Intervention: Allopurinol (300 mg daily for 4 weeks)
Number of subjects: 9
Study 10549401 — intervention group
Group type: COMPARATOR
Intervention: Control (placebo)
Number of subjects: 9
Study 7885804 — intervention group
Group type: EXPERIMENTAL
Intervention: Sweet (sucrose)
Number of subjects: 0
Study 7885804 — intervention group
Group type: EXPERIMENTAL
Intervention: Salty (sodium chloride)
Number of subjects: 0
Study 7885804 — intervention group
Group type: EXPERIMENTAL
Intervention: Sour (citric acid)
Number of subjects: 0
Study 7885804 — intervention group
Group type: EXPERIMENTAL
Intervention: Bitter (quinine hydrochloride)
Number of subjects: 0
Study 7885804 — intervention group
Group type: EXPERIMENTAL
Intervention: 11 possible mixtures of sweet, salty, sour, and bitter
Number of subjects: 0
Study 2505187 — intervention group
Group type: COMPARATOR
Intervention: L-carnitine (2 g/day) for 6 weeks
Number of subjects: 6
Study 2505187 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 6
Study 1277709 — intervention group
Group type: EXPERIMENTAL
Intervention: Bumetanide 1 mg
Number of subjects: 16
Study 1277709 — intervention group
Group type: COMPARATOR
Intervention: Furosemide 40 mg
Number of subjects: 16
Study 1277709 — intervention group
Group type: EXPERIMENTAL
Intervention: Bumetanide 1 mg and Furosemide 40 mg
Number of subjects: 16
Study 31669455 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasonic bone scalpel (BoneScalpel; Misonix, Farmingdale, NY)
Number of subjects: 34
Study 31669455 — intervention group
Group type: COMPARATOR
Intervention: Piezoelectric surgical device
Number of subjects: 34
Study 31669455 — intervention group
Group type: COMPARATOR
Intervention: Conventional technique (Lindeman burr and reciprocal saw)
Number of subjects: 34
Study 31324357 — intervention group
Group type: EXPERIMENTAL
Intervention: Acute CAG (<2 hours)
Number of subjects: 496
Study 31324357 — intervention group
Group type: COMPARATOR
Intervention: Subacute CAG (<72 hours)
Number of subjects: 496
Study 27462047 — intervention group
Group type: EXPERIMENTAL
Intervention: Educational lecture delivered by a physician
Number of subjects: 27
Study 25729878 — intervention group
Group type: EXPERIMENTAL
Intervention: N-acetylcysteine (NAC) 3 g/day
Number of subjects: 34
Study 25729878 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 34
Study 23118056 — intervention group
Group type: EXPERIMENTAL
Intervention: Simulated altitude (3000 m) for 10 h/night for 21 nights
Number of subjects: 14